| RS796052899 |
POLG
|
Health Risk |
Pathogenic/Likely pathogenic |
Progressive sclerosing poliodystrophy, POLG-related disorder |
| RS796052906 |
POLG
|
Health Risk |
Pathogenic/Likely pathogenic |
Progressive sclerosing poliodystrophy, Progressive external ophthalmoplegia with mitochondrial DNA deletions |
| RS796052907 |
POLG
|
Health Risk |
Pathogenic |
— |
| RS796052908 |
POLG
|
Health Risk |
Pathogenic |
Global developmental delay, Obesity |
| RS796052913 |
POLG
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive sclerosing poliodystrophy, Progressive sclerosing poliodystrophy |
| RS796052916 |
POLG
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive sclerosing poliodystrophy, Progressive sclerosing poliodystrophy |
| RS796052919 |
POLG
|
Health Risk |
Pathogenic/Likely pathogenic |
Progressive sclerosing poliodystrophy, Progressive sclerosing poliodystrophy |
| RS796052923 |
PPT1
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 1, Neuronal ceroid lipofuscinosis 1 |
| RS796052924 |
PPT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis 1, Neuronal ceroid lipofuscinosis 1 |
| RS796052925 |
PPT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuronal ceroid lipofuscinosis 1, Neuronal ceroid lipofuscinosis 1 |
| RS796052927 |
PPT1
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 1, Neuronal ceroid lipofuscinosis 1 |
| RS796052936 |
PRRT2
|
Health Risk |
Likely pathogenic |
— |
| RS796052938 |
PRRT2
|
Health Risk |
Likely pathogenic |
Episodic kinesigenic dyskinesia, Seizure |
| RS796052940 |
PRRT2
|
Health Risk |
Pathogenic |
— |
| RS796052941 |
PRRT2
|
Health Risk |
Pathogenic/Likely pathogenic |
Episodic kinesigenic dyskinesia, Episodic kinesigenic dyskinesia 1 |
| RS796052943 |
PRRT2
|
Health Risk |
Pathogenic |
— |
| RS796052944 |
PRRT2
|
Health Risk |
Pathogenic |
— |
| RS796052949 |
SCARB2
|
Health Risk |
Pathogenic |
— |
| RS796052952 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS796052953 |
SCN1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, Early-infantile DEE |
| RS796052954 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS796052957 |
SCN1A
|
Health Risk |
Likely pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS796052959 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS796052960 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS796052961 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS796052962 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS796052963 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS796052964 |
SCN1A
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS796052965 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS796052971 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS796052972 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Developmental and epileptic encephalopathy |
| RS796052973 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS796052974 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS796052976 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS796052977 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS796052982 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS796052983 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS796052984 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS796052985 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS796052986 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS796052987 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS796052988 |
SCN1A
|
Health Risk |
Likely pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS796052989 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS796052990 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS796052991 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe myoclonic epilepsy in infancy, Developmental and epileptic encephalopathy 6B |
| RS796052993 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS796052994 |
SCN1A
|
Health Risk |
Likely pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS796052995 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS796052997 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS796052999 |
SCN1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, Severe myoclonic epilepsy in infancy |
| RS796053000 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS796053001 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe myoclonic epilepsy in infancy, Generalized epilepsy with febrile seizures plus |
| RS796053004 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Inborn genetic diseases |
| RS796053005 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS796053006 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS796053007 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Early-infantile DEE |
| RS796053008 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS796053009 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS796053010 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe myoclonic epilepsy in infancy, SCN1A-related disorder |
| RS796053011 |
SCN1A
|
Health Risk |
Pathogenic |
SCN1A-related disorder, Early-infantile DEE |
| RS796053014 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS796053015 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS796053016 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS796053017 |
SCN1A
|
Health Risk |
Likely pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS796053018 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS796053019 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS796053020 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS796053021 |
SCN1A
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS796053022 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS796053024 |
SCN1A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS796053025 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS796053026 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS796053029 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS796053030 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS796053031 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS796053032 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS796053033 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS796053035 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant epilepsy, Inborn genetic diseases |
| RS796053036 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS796053037 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
See cases, Early-infantile DEE |
| RS796053038 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS796053039 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS796053040 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS796053041 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS796053042 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Early-infantile DEE |
| RS796053043 |
SCN1A
|
Health Risk |
Likely pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS796053046 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS796053047 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS796053048 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS796053049 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS796053050 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS796053051 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS796053052 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS796053053 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS796053054 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS796053055 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS796053056 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS796053057 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS796053058 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS796053059 |
SCN1A
|
Health Risk |
Pathogenic |
— |